LifeTime Revolutionizing Healthcare by Tracking and Understanding Human Cells during Disease
Geneviève Almouzni (Institut Curie / CNRS) and Nikolaus Rajewsky (Max Delbrück Centrer for Molecular Medecine, Helmholtz Association) coordinate the LifeTime1 initiative, led by a consortium of eighteen organizations across Europe and a network of more than fifty prestigious European institutions,with the support of several Academies of Science including those of France, Germany and the Netherlands as well as the Royal Society.
30 november 2018 - 9am to 1pm
Centre de Recherche - Institut Curie, Paris
to register : http://minilien.curie.fr/ghzwb9
LifeTime: an ambitious interdisciplinary scientific and technological project to quantify and model cellular trajectories in health, to detect and predict their deviation during disease progressions and to find targeted perturbations to steer trajectories in disease back to health.The development and application of state-of-the-art technologies for omics and single-cell imaging, artificial intelligence, and machine learning will lead toinnovative solutions for the early diagnosis and effective treatment of diseases.
Supported by sharedtools, technology development,andstandardization, the creation of a network of LifeTime Cell Centers (including virtual centers) will result in new applications in medicine and foster innovation.The initiative,characterized by its open spirit,aims to attract the best talentandto bring out the most creative and innovative projects. It has strong linkswith the large international initiatives of the field,which aim in particular to map the diversity of the cells (Human Cell Atlas) and the organization of the nucleus (4Dnucleome)